General

Revvity Inc. (NYSE:RVTY) stock is trading lower on Monday following the life science tools maker’s second-quarter 2025 earnings report, which also included a trimmed profit forecast for 2025. The Massachusetts-based company announced second-quarter sales of $720.28 million, an increase from...

Chinese biotech company Hengrui Pharma partnered with GSK plc (NYSE:GSK) on Monday to develop up to 12 medicines. These agreements will add significant value to Hengrui’s globalization strategy and provide GSK with significant new growth opportunities beyond 2031. The programs were selected...

CervoMed Inc. (NASDAQ:CRVO) on Monday shared 32-week data from the Extension phase of its Phase 2b RewinD-LB trial evaluating oral neflamapimod in patients with Dementia with Lewy Bodies (DLB). The initial 16-week, randomized, double-blind, placebo-controlled portion of the study included 159 DLB...

Biotechnology firms are increasingly turning to innovative combination therapies to tackle hard-to-treat cancers, with promising results sparking investor interest. AIM ImmunoTech Inc. (NYSE:AIM) is the latest to capture attention, as its stock soars following a promising mid-year update from the...

Amid a surge in research targeting cognitive disorders, the pharmaceutical industry is witnessing a wave of pivotal trial results that could reshape schizophrenia treatment paradigms. As biotech firms race to develop innovative therapies, Recognify Life Sciences steps into the spotlight with new...

Celcuity Inc. (NASDAQ:CELC) stock surged on Monday after the company reported topline results from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial, which evaluated gedatolisib plus fulvestrant with and without palbociclib versus fulvestrant. The trial included adult patients with...

The U.S. Food and Drug Administration (FDA) announced on Friday, after market close, that it is investigating the death of an 8-year-old boy who had received Elevidys, Sarepta Therapeutics Inc.’s (NASDAQ:SRPT) gene therapy for Duchenne muscular dystrophy. The death occurred on June 7, 2025,...

Billionaire entrepreneur and investor Mark Cuban says schools that still teach for model-ready answers will be “way behind” within a decade, arguing curricula must evolve with artificial intelligence. What Happened: In an X post on Sunday, the investor wrote, “Within 5–10 years,...

Former hedge fund manager Steve Eisman, known for his role in predicting the 2008 financial crisis, is sounding the alarm on what he sees as a resurgence of “meme” stock mania, this time centered around Opendoor Technologies Inc. (NASDAQ:OPEN). Check out the current price of OPEN...

NASA is preparing to shrink its workforce by approximately 20%, with nearly 4,000 civil servants expected to depart through a voluntary resignation program aimed at streamlining operations under the Donald Trump administration's broader federal workforce reduction plan. The space agency announced...

These ten large-cap stocks were top performers last week. Are they a part of your portfolio? 1. Medpace Holdings, Inc. (NASDAQ:MEDP) gained over 137.10% in the last week after the company reported second-quarter earnings per share of $3.10, beating the consensus estimate of $2.97. 2. ICON plc...

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio? Liberty Broadband Corporation (NASDAQ:LBRDK) stock lost 20.50% last week following a second quarter earnings miss from Charter Communications, Inc. (NASDAQ:CHTR) STMicroelectronics (NYSE:STM)...